Download PDF
Horm Metab Res 2007; 39(6): 425-429
DOI: 10.1055/s-2007-980191
Original

© Georg Thieme Verlag KG Stuttgart · New York

Interindividual Glucocorticoid Sensitivity in Young Healthy Subjects: The Role of Glucocorticoid Receptor α and β Isoforms Ratio

L. M. Colli 1 , F. C. do Amaral 1 , N. Torres 1 , M. de Castro 1
  • 1Department of Internal Medicine, School of Medicine of Ribeirao Preto, University of Sao Paulo, Sao Paulo, Brazil
Further Information

Publication History

received 21. 11. 2006

accepted 29. 1. 2007

Publication Date:
18 June 2007 (online)

Also available at
    Permissions and Reprints

Abstract

Only few studies have addressed the interindividual variation and tissue specificity of glucocorticoid (GC) sensitivity in healthy individuals, a phenomenon observed in pathological conditions. Alternative splicing of the glucocorticoid receptor (GR) produces α and β isoforms. GRβ has dominant-negative effects on hormone-induced GRα effects, and an increased expression of the GRβ has been associated with glucocorticoid resistance. We determined, using a simple, rapid, and accurate Real-Time PCR assay, the individual mRNAs expression of GRα and GRβ in 26 normal subjects (mean±SE, age 30±6 years; 12 males and 14 females), in order to evaluate the role of these isoforms in glucocorticoid sensitivity in health. Glyceraldehydes-3-phosphate dehydrogenase (GAPDH) was used as a housekeeper gene. GRα/GAPDH, GRβ/GAPDH and GRα/GRβ ratios showed a normal distribution. We observed a higher expression of GRα compared to GRβ and an interindividual variability in the GRα, GRβ, and GAPDH gene expressions in the young healthy population. In addition, no correlation was observed between GRα/GRβ ratio and the dexamethasone (DEX) doses needed to suppress plasma cortisol, GRα/GRβ ratio and the concentration of DEX that caused inhibition of Con-A stimulated cell proliferation, and GRα/GRβ ratio and the affinity of GR (Kd) of each subject. Therefore, the variability of GC sensitivity observed in normal subjects can not be ascribed to the variation in the GRα and GRβ expression.

Key words

Glucocorticoid receptor α and β isoforms - glucocorticoid sensitivity - real time PCR

References

  • 1 Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates.  Ann Intern Med. 1993;  119 1198-1208
    CrossrefPubMedGoogle Scholar
  • 2 Barnes PJ, Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases.  N Engl J Med. 1997;  336 1066-1071
    CrossrefPubMedGoogle Scholar
  • 3 Bamberger CM, Schulte HM, Chrousos GP. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids.  Endocr Rev. 1996;  17 245-261
    CrossrefPubMedGoogle Scholar
  • 4 Evans RM. The steroid and thyroid hormone receptor superfamily.  Science. 1998;  240 889-895
    PubMedGoogle Scholar
  • 5 Tsai M-J, O’Malley BW. Molecular mechanism of action of steroids/thyroid receptor superfamily members.  Ann Rev Biochem. 1994;  63 451-486
    CrossrefPubMedGoogle Scholar
  • 6 Pratt WB. The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor.  J Biol Chem. 1993;  268 21455-21458
    PubMedGoogle Scholar
  • 7 Yang-Yen HF, Chambard JC, Sun YL, Smeal T, Schmidt TJ, Drouin J, Karin M. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction.  Cell. 1990;  62 1205-1215
    CrossrefPubMedGoogle Scholar
  • 8 Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin Jr AS. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors.  Mol Cell Biol. 1995;  15 943-953
    PubMedGoogle Scholar
  • 9 Yudt MR, Cidlowski JA. Molecular identification and characterization of α and β forms of the glucocorticoid receptor.  Mol Endocrinol. 2001;  15 1093-1103
    CrossrefPubMedGoogle Scholar
  • 10 Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, Evans RM. Primary structure and expression of a functional human glucocorticoid receptor cDNA.  Nature. 1985;  318 635-641
    CrossrefPubMedGoogle Scholar
  • 11 Bamberger CM, Bamberger AM, de Castro M, Chrousos GP. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans.  J Clin Invest. 1995;  95 2435-2441
    PubMedGoogle Scholar
  • 12 Castro M, Elliot S, Kino T, Bamberger C, Karl M, Webster E, Chrousos GP. The non-ligand binding beta-isoform of the human glucocorticoid receptor (hGR beta): tissue levels, mechanism of action, and potential physiologic role.  Mol Med. 1996;  2 597-607
    PubMedGoogle Scholar
  • 13 Oakley RH, Sar M, Cidlowski JA. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function.  J Biol Chem. 1996;  271 9550-9559
    CrossrefPubMedGoogle Scholar
  • 14 Leung DYM, Hamid Q, Vottero A, Szefler JS, Surs W, Minshall E, Chrousos GP, Klemm DJ. Association of glucocorticoid insensitivity with increase expression of glucocorticoid receptor β.  J Exp Med. 1997;  186 1567-1574
    CrossrefPubMedGoogle Scholar
  • 15 Hamid QA, Wenzel SE, Hauk PJ, Tsicopoulos A, Wallaert B, Lafitte JJ, Chrousos P, Szefler SJ, Leung DY. Increased glucocorticoid receptor β in airway cells of glucocorticoid-insensitive asthma.  Am J Respir Crit Care Med. 1999;  159 1600-1604
    PubMedGoogle Scholar
  • 16 Honda M, Orii F, Ayabe T, Imai S, Ashida T, Obara T, Kohgo Y. Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis.  Gastroenterology. 2000;  118 859-866
    PubMedGoogle Scholar
  • 17 Derijk RH, Schaaf MJ, Turner G, Datson NA, Vreugdenhil E, Cidlowski J, de Kloet ER, Emery P, Sternberg EM, Detera-Wadleigh SD. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis.  J Rheumatol. 2001;  28 2383-2388
    PubMedGoogle Scholar
  • 18 Chriguer RS, Elias LLK, Silva IMJ, Vieira JGH, Moreira AC, Castro M. Glucocorticoid sensitivity in young healthy individuals: in vitro and in vivo studies.  J Clin Endocrinol Metab. 2005;  90 5978-5984
    CrossrefPubMedGoogle Scholar
  • 19 Oakley RH, Webster JC, Jewell CM, Sar M, Cidlowski JA. Immunocytochemical analysis of the glucocorticoid receptor a isoform (GRa) using GRa-specific antibody.  Steroids. 1999;  64 742-751
    CrossrefPubMedGoogle Scholar
  • 20 Ramakers C, Ruijter JM, Lekanne Deprez RH, Moorman AFM. Assumption-free analysis of quantitative real-time PCR data.  Neurosci Lett. 2003;  339 62-66
    CrossrefPubMedGoogle Scholar
  • 21 Ebrecht M, Buske-Kirschbaum A, Hellhammer D, Kern S, Rohleder N, Walker B, Kirschbaum C. Tissue specificity of glucocorticoid sensitivity in healthy adults.  J Clin Endocrinol Metab. 2000;  85 3733-3739
    CrossrefPubMedGoogle Scholar
  • 22 Walker BR, Best R, Shackleton CH, Padfield PL, Edwards CR. Increased vasoconstrictor sensitivity to glucocorticoids in essential hypertension.  Hypertension. 1996;  27 190-196
    PubMedGoogle Scholar
  • 23 vanRijen E, Harvey RA, Barton RN, Rose JG, Horan MA. Sensitivity of mononuclear leucocytes to glucocorticoids in elderly hip-fracture patients resistant to suppression of plasma cortisol by dexamethasone.  Eur J Endocrinol. 1998;  138 659-666
    CrossrefPubMedGoogle Scholar
  • 24 Brown PH, Teelucksingh S, Matusiewicz SP, Greening AP, Crompton GK, Edwards CR. Cutaneous vasoconstrictor response to glucocorticoids in asthma.  Lancet. 1991;  337 576-580
    CrossrefPubMedGoogle Scholar
  • 25 Lowy MT, Reder AT, Gormley GJ, Meltzer HY. Comparison of in vivo and in vitro glucocorticoid sensitivity in depression: relationship to the dexamethasone suppression test.  Biol Psychiatry. 1988;  24 619-630
    CrossrefPubMedGoogle Scholar
  • 26 Johnson MR, Wang K, Smith JB, Heslin MJ, Diasio RB. Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction.  Anal Biochem. 2000;  278 175-184
    CrossrefPubMedGoogle Scholar
  • 27 Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2[-Delta Delta C(T)] method.  Methods. 2001;  25 402-408
    CrossrefPubMedGoogle Scholar
  • 28 Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR.  Nucleic Acids Res. 2001;  29 2002-2007
    PubMedGoogle Scholar
  • 29 Tichopad A, Dilger M, Schwarz G, Pfaffl MW. Standardized determination of real-time PCR efficiency from a single reaction set-up.  Nucleic Acids Res. 2003;  31 6688-6693
    CrossrefPubMedGoogle Scholar
  • 30 Huizenga NA, Koper JW, de Lange P, Pols HA, Stolk RP, Grobbee DE, de Jong FH, Lamberts SW. Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals.  J Clin Endocrinol Metab. 1998;  83 47-54
    CrossrefPubMedGoogle Scholar
  • 31 Weiner MF, Davis BM, Mohs RC, Davis KL. Influence of age and relative weight on cortisol suppression in normal subjects.  Am J Psychiatry. 1987;  144 646-649
    PubMedGoogle Scholar
  • 32 Weaver JU, Hitman GA, Kopelman PG. An association between a Bc1I restriction fragment length polymorphism of the glucocorticoid receptor locus and hyperinsulinaemia in obese women.  J Mol Endocrinol. 1992;  9 295-300
    PubMedGoogle Scholar
  • 33 Georgotas A, McCue RE, Kim OM, Hapworth WE, Reisberg B, Stoll PM, Sinaiko E, Fanelli C, Stokes PE. Dexamethasone suppression in dementia, depression, and normal aging.  Am J Psychiatry. 1986;  143 452-456
    PubMedGoogle Scholar
  • 34 Sher ER, Leung DY, Surs W, Kam JC, Zieg G, Kamada AK, Szefler SJ. Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy.  J Clin Invest. 1994;  93 33-39
    PubMedGoogle Scholar
  • 35 de Antonio SR, Blotta HM, Mamoni RL, Louzada P, Bertolo MB, Foss NT, Moreira AC, Castro M. Effects of dexamethasone on lymphocyte proliferation and cytokine production in patients with rheumatoid arthritis.  J Rheumatol. 2002;  29 46-51
    PubMedGoogle Scholar
  • 36 Carlotti AP, Franco PB, Elias LL, Facincani I, Costa EL, Foss N, Moreira AC, de Castro M. Glucocorticoid receptors, in vitro steroid sensitivity, and cytokine secretion in idiopathic nephritic syndrome.  Kidney Int. 2004;  65 403-408
    CrossrefPubMedGoogle Scholar
  • 37 Hirano T, Oka K, Sakurai E, Tamaki T, Kozaki M. Impaired prednisolone sensitivities of the endocrine system and peripheral-blood lymphocytes are closely related to clinical incidence in renal transplantation.  J Pharm Pharmacol. 1991;  43 569-573
    PubMedGoogle Scholar
  • 38 Olsen NJ, Stein CM. New drugs for rheumatoid arthritis.  N Engl J Med. 2004;  350 2167-2179
    CrossrefPubMedGoogle Scholar
  • 39 Goecke A, Guerrero J. Glucocorticoid receptor beta in acute and chronic inflammatory conditions: clinical implications.  Immunobiology. 2006;  211 85-96
    CrossrefPubMedGoogle Scholar
  • 40 Holgate ST, Polosa R. The mechanisms, diagnosis, and management of severe asthma in adults.  Lancet. 2006;  368 780-793
    CrossrefPubMedGoogle Scholar

Correspondence

M. de Castro

School of Medicine of Ribeirao Preto

University of Sao Paulo

Avenida dos Bandeirantes 3900

14049-900 Ribeirao Preto

Sao Paulo

Brazil

Phone: +55/16/3602 29 40

Fax: +55/16/3633 66 95

Email: castrom@fmrp.usp.br

      >